Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma

Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar, Evelyn Icasiano, Geralyn Higgins, Harry Herr, Dean F. Bajorin

Investigational New Drugs · 2000 · 23 citations · 20 references

Concepts

References

20